A Promising New Strategy for Treating Triple-Negative Breast Cancer
Brigham and Women’s Hospital Research Briefs | October 9, 2024
Published in Nature - research led by Karen Cichowski’s lab in collaboration with several LSP members (including Yilin Xu, Jia-Ren Lin, Peter Sorger, and Sandro Santagata) suggests that combined treatment with AKT and EZH2 inhibitors kills TNBC cells more effectively in in vivo models. This work could provide a promising new therapeutic strategy for treating TNBC.
Latest News
March 25, 2025
Albers Lab at MGH develops new at-home test for brain health
March 24, 2025
Laura König prepares to run the 129th Boston Marathon
February 4, 2025
Tuulia Vallius awarded American Cancer Society Postdoctoral fellowship
February 4, 2025
Jeremiah Wala receives a Wong Family Award in translational oncology for 2025
